• HOME
  •  > 
  • 薬学
  •  > 
  • 薬物学
  •  >  これだけは知っておきたい　飲食物と薬の相互作用

これだけは知っておきたい　飲食物と薬の相互作用

出版社： 永井書店
著者：
発行日： 2006-06-15
分野： 薬学  >  薬物学
ISBN： 4815917566
電子書籍版： 2006-06-15 （第1版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

1,980 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

990 円(税込)

購入する

商品紹介

本書では、第I部で薬物相互作用の基礎をまとめ、次いで第II部で16の飲食物を取りあげ、それぞれの飲食物と薬との相互作用に関する臨床例を示し、相互作用の機序、使用上の注意および服薬指導の内容についてまとめた。

目次

  • これだけは知っておきたい　飲食物と薬の相互作用

    ―目次―

    1．総論　薬物相互作用の基礎

    2．各論
    　第1章　グレープフルーツジュースと薬
    　第2章　ハーブと薬
    　第3章　緑茶と薬
    　第4章　タバコと薬
    　第5章　カフェイン含有食品と薬
    　第6章　アルコールと薬
    　第7章　ビタミンと薬
    　第8章　カルシウム、マグネシウムおよびアルミニウムと薬
    　第9章　カリウム含有食品と薬
    　第10章　炭火焼き食品と薬
    　第11章　モノアミンおよびヒスタミン含有食品と薬
    　第12章　セロトニン含有食品と薬
    　第13章　日本食と薬
    　第14章　酸性飲料と薬
    　第15章　脂肪と薬
    　第16章　一般用医薬品（OTC薬）と他薬

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[II] 各論

P.16 掲載の参考文献
1) 大森正規, 荒川昌史, 新木信隆, ほか:一般内科外来における大衆薬および嗜好品の使用状況調査:preliminary report. 臨床薬理341141-142, 2002.
 
2) Pisarik P:Blood pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a patient with severe renovascular hypertension. Arch Fam Med 5:413-416, 1996.
 
3) Lee M, Min DI:Determination of sildenafil citrate in plasma by high-performance liquid chromatography and a case for the potential interaction of grapefruit juice with sildenafil citrate. Ther Drug Monit 23:21-26, 2001.
 
4) Bonin B, Vandel P, Vandel S, et al:Effect of grapefruit intake on carbamazepine bioavailability; a case report. Therapie 56:69-71, 2001.
PubMed
5) Spence JD:Drug interactions with grapefruit; Whose responsibility is it to warn the public? Clin Pharmacol Ther 61:395-400, 1997.
PubMed
6) Bailey DG, Spence JD, Munoz C, et al:Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269, 1991.
PubMed
7) Ameer B, Weintraub RA:Drug interactions with grapefruit juice. Clin Pharmacokinet 33:103-121, 1997.
PubMed
8) http://www.fda.gov/cder/consumerinfo/viagra/default.htm(ホームページ)
 
9) Garg SK, Kumar N, Bhargava VK, et al:Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 64:286-288, 1998.
PubMed
1O) http://wwwl.mhlw.go.jp/houdou/0902/hO213-2.html(ホームページ)
 
11) Bailey DG, Arnold MO, Spence JD:Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101-110, 1998.
 
12) 藤村昭夫 (編著):疾患別これでわかる薬物相互作用. 第3版, 日本医事新報社, 東京, 2006.
 
13) Taniguchi S, Kobayashi H, Ishii M:Treatment of psoriasis by cyclosporine and grapefruit juice. Arch Dermatol 132:1249, 1996.
PubMed
14) Chobanian AV, Bakris GL, Black HR, et al:The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; The JNC 7 report. JAMA 21:2534-2573, 2003.
 
15) Vincent J, Harris SI, Foulds G, et al:Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Br J Clin Pharmacol 50:455-463, 2000.
PubMed
16) Josefsson M, Ahlner J:Amlodipine and grapefruit juice. Br J Clin Pharmacol 53:403-410, 2002.
 
17) Lundahl J, Regardh CG, Edgar B, et al:Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 49:61-67, 1995.
PubMed
18) 大森正規, 藤村昭夫:高齢者, 腎および肝機能障害患者の薬物治療で注意すべきポイント. 産婦人科の実際.女性診療科における薬物療法のタイミング; いつ始めるか, いつ打ち切るか, Vol. 51, No. 11, pp 1537-1545, 金原出版, 東京, 2002.
 
19) Bailey DG, Dresser GK, Kreeft JH, et al:Grapefruit-felodipine interaction; effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 68:468-477, 2000.
PubMed
20) Penzak SR, Acosta EP, Turner M, et al:Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics. J Clin Pharmacol 42:1165-1170, 2002.
PubMed
P.47 掲載の参考文献
1) Eisenberg DM, Davis RB, Ettner SL, et al:Trends in alternative medicine use in the united states, 1990-1997. JAMA 280:1569-1575, 1998.
PubMed
2) Izzo AA, Ernst E:Possible interaction between herbal medicines and prescribed drugs; A systemic review. Drugs 61:2163-2175, 2001.
 
3) 大森正規, 荒川昌史, 新木信隆, ほか:一般内科外来における大衆薬および嗜好品の使用状況調査-preliminary report-. 臨床薬理34:141-142, 2002.
 
4) Ruschitzka F, Meier PJ, Turina M, et al:Acute heart transplant rejection dueto Saint John's wort. Lancet 355:548-549, 2000.
 
5) Bolley R, Zulke C, Kammerl M, et al:Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP 3 A 4 system with St John's wort. Transplantation 27:73, 2002.
 
6) Schwarz UI, Buschel B, Kirch W:Unwanted pregnancy on self-medication with St John's wort despite hormone contraception. Br J Clin Pharmacol 55:112-113, 2003.
PubMed
7) Gordon JB:SSRIs and St. John's wort toxicity? Am Fam Phys 57:950-953, 1998.
 
8) Sugimoto K, Ohmori M, Tsuruoka S, et al:Different effect of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 70:518-524, 2002.
 
9) Mills KC:Serotonin syndrome. Am Fam Physician 52:1475-1482, 1995.
PubMed
10) Triffaux JM, Wauthy J, Albert A, et al:Psychological distress of surgical patients after orthotopic heart transplantation. Transpl Int 14:391-395, 2001.
PubMed
11) Rubin NJ:Severe asthma and depression. Arch Fam Med 2:433-440, 1993.
PubMed
12) Conn JW, Rovner DR, Cohen EL:Licorice-induced pseudoaldosteronism. JAMA 205:80-84, 1968.
 
13) Harada T, Ohtaki E, Misu K, et al:Congestive heart failure caused by digitalis toxicity in and elderly man taking a licorice-containing Chinese herbal laxative. Cardiology 98:218, 2002.
PubMed
14) Tanahashi T, Mune T, Morita H, et al:Glycyrrhizic acid suppresses type 211 beta-hydroxysteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biol 80:441-447, 2002.
 
15) Mattingly D, Tyler C, Bilton E:Plasma II-hydroxycorticoid levels after carbenoxolone sodium. Br J Med 2:498-500, 1970.
 
16) Ulmann A, Menard J, Corvol P:Binding of glycyrrhetinic acid to kidney mineralocorticoid receptors. Endocrinology 97:46-51, 1975.
PubMed
17) Issac G, Holland OB:Drug-induced hypokalaemin; A cause for concern. Drug Aging 2:35-41, 1992.
 
18) Dunn CJ, Fitton A, Brogden RN:Torasemide; An update of its pharmacological properties and therapeutic efficacy. Drugs 49:121-42, 1995.
PubMed
19) 猿田享男 (監修):カンゾウ (甘草) 含有医療用漢方製剤による低カリウム血症の防止と治療法. 日本漢方生薬製剤協会頒布資料, 2002.
 
20) de Klerk GJ, Nieuwenhuis MG, Beutler JJ:Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ 314:731-732, 1997.
PubMed
21) Kamei H, Arakawa K:A case of pseudoaldosteronism due to addiction of Jintan, a mouth refresher popular among Japanese. Jpn Heart J 1982:651-659, 1982.
PubMed
22) Aslam M, Stockley IH:Interaction between curry ingredient (karela) and drug (chloropropamide). Lancet 17:607, 1979.
 
23) Sunter W:Warfarin and garlic. Pharmaceut J 246:722-723, 1991.
 
24) Piscitelli SC, Burstein AH, Welden N, et al:The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234-238, 2002.
PubMed
25) Matthews MK:Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50:1933-1934, 1998.
PubMed
26) Rosenblatt M, Mindel J:Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 336:1108, 1997.
PubMed
27) Shaw D, Leon C, Kolev S, et al:Traditional remedies and food supplements; A 5-year toxicological study (1991-1995). Drug Saf 17:342-356, 1997.
PubMed
28) Jones BD, Runikis AM:Interaction of Ginseng with phenelzine. J Clin Psychopharmacol 7:201-202, 1987.
PubMed
29) Janetsky K, Morreale AP:Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 54:692-693, 1987.
 
30) Becker BN, Greene J, Evanson J, et al:Ginseng-induced diuretic resistance. JAMA 28:606-607, 1996.
 
31) McRae S:Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ 155:293-295, 1996.
 
32) Coon JT, Ernst E:Panax ginseng; a systematic review of adverse effects and drug interactions. Drug Safety 25:323-344, 2002.
PubMed
33) Rosado MF:Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product. Cardiology 99:111, 2003.
 
34) Almeida JC, Grimsley EW:Coma from the health food store; interaction between Kava and alprazolam. Ann Intern Med 125:940-941, 1996.
PubMed
35) Lam AY, Elmer GW, Mohutsky MA:Possible interaction between warfarin and Lycium barbarum L. Ann Pharmacother 35:1199-1201, 2001.
PubMed
36) Tormey WP, Bruzzi A:Acute psychosis due to the interaction of legal compounds; ephedra alkaloids in ?vigueur fit' tablets, caffeine in ?red bull' and alcohol. Med Sci Law 41:331-336, 2001.
 
37) Spigset O:Reduced effect of warfarin caused by ubidecarenone. Lancet 344:1372-1373, 1994.
PubMed
38) Takahashi J, Kawakatsu K, Wakayama T, et al:Elevation of serum theophylline levels by ipriflavone in a patient with chronic obstructive pulmonary disease. Eur J Clin Pharmacol 43:207-208, 1992.
 
39) Page RL II, Lawrence JD:Potentiation of warfarin by don quai. Pharmacotherapy 19:870-876, 1999.
 
40) Lambert JP, Cormier A:Potential interaction between warfarin and boldofenugreek. Pharmacotherapy 21:509-512, 2001.
 
41) Izzat MB, Yim APC, EI-Zufari MH:A taste of chinese medicine! Ann Thorac Surg 66:941-942, 1998.
 
42) Perlman BB:Interaction between lithium salts and ispaghula husk. Lancet 17:416, 1990.
 
43) Mustapha A, Yakasai IA, Abudu aguye I:Effect of Tamarindus indica L; on the bioavailability of aspirin in healthy human volunteers. Eur J Drug Metab Pharmacokinet 21:223-226, 1996.
 
44) Shaw D, Leon C, Kolev S, et al:Traditional remedies and food supplements. Drug Safety 17:342-356, 1997.
PubMed
45) Homma M, Oka K, Ikeshima K, et al:Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 47:687-692, 1995.
PubMed
46) Attef OA, Ali A-AA, Ali HM:Effect of Khat chewing on the bioavailability of ampicillin and amoxycillin. J Antimicrob Chemother 39:523-525, 1997.
 
47) Dourakis SP, Papanikolaou IS, Tzemanakis EN, et al:Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur J Gastroenterol Hepatol 14:693-695, 2002.
PubMed
48) Takeshita K, Saisho Y, Kitamura K, et al:Pneumonitis induced by ou-gon (skullcap). Intern Med 40:764-768, 2001.
 
49) Patel S, Robinson R, Burk M:Hypertensive crisis associated with St John's wort. Am J Med 112:507-508, 2002.
PubMed
50) Miller JG:Herbal medicinals. Arch Intern Med 158:2200-2211, 1998.
 
51) Scott GN, Elmer GW:Update on natural product-drug interactions. Am J Health-Syst Pharm 59:339-347, 2002.
PubMed
P.52 掲載の参考文献
1) Morris ER:An overview of current information on bioavailability of dietary iron to humans. Fed Proc 42:1716-1720, 1983.
PubMed
2) 原田契一:茶と鉄剤; 緑茶の飲用は徐放性鉄剤の効果に影響を与えない. 日本薬剤師会雑誌 38:1145-1148, 1986.
 
3) 溝口秀昭, 山口 修, 倉根理一, ほか:鉄欠乏性貧血に対するクエン酸第一鉄ナトリウム(フェロミア(R)) による治療効果に及ぼす緑茶飲用の影響. 診療と新薬 26:1373-1378, 1989.
 
4) Lynch SR, Cook JD:Interaction of vitamin C and iron. Ann N Y Acad Sci 355:32-44, 1980.
PubMed
5) 溝口秀昭:鉄欠乏性貧血今日の治療指針. pp 524-525, 医学書院, 東京, 2001.
 
P.59 掲載の参考文献
1) 日本呼吸器学会:禁煙宣言. 2003 (http://www. jrs. or. jp/citizen/topics/sengen j. html) (ホームページ)
 
2) Sato H, Araki S:Yields and daily consumption of cigarettes in Japan in 1969-1996. J Epidemiol 10:7-15, 2000.
PubMed
3) Nicholson JP, Basile SA, Cury JD:Massive theophylline dosing in a heavy smoker receiving both phenytoin and phenobarbital. Ann Pharmacother 26:334-336, 1992.
 
4) Ciszewski M, Sokolwska-Oracz A, Ruzyllo W:Myocardial infarction in young female smoker taking oral contraceptives. Pol Arch Med Wewn 106:699-704, 2001.
 
5) Chu G, Farrell GC:Portal vein thrombosis associated with prolonged ingestion of oral contraceptive steroids. J Gastroenterol Hepatol 8:390-393, 1993.
PubMed
6) Zevin S, Benowitz NL:Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36:425-438, 1999.
PubMed
7) Schein JR:Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29:1139-1148, 1995.
PubMed
8) Klemp P, Staberg B, Madsbad S, et al:Smoking reduces insulin absorption from subcutaneous tissue. Brit Med J 284:237, 1982.
 
9) Ohmori M, Sugimoto K, Araki N, et al:TDM of theophylline as a laboratory exercise for education in clinical pharmacology. 14th World Congress of Pharmacology, San Francisco, 2002 (Abstract:p116).
 
10) Mayo PR:Effect of passive smoking on theophylline clearance in children. Ther Drug Monit 23:503-505, 2001.
PubMed
11) Kurisu MS, Plezia P, Karol M, et al:Effect of passive smoking on theophylline clearance. Clin Pharmacol Ther 46:399-407, 1989.
 
12) Stadel BV:Oral contraceptives and cardiovascular disease. N Engl J Med 305:612-618, 1981.
PubMed
13) Davis MC, Matthews KA:Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress. Health Psychol 9:717-736, 1990.
PubMed
14) Kool MJ, Hoeks AP, Struijker Boudier HA, et al:Short-and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 22:1881-1886, 1993.
 
15) Rees PJ:New guideline on the management of asthma. Brit Med J 326:346-347, 2003.
PubMed
16) 藤村昭夫 (編著):時間治療学:投薬のタイミングと効果. 日本医事新報社, 東京, 2000.
 
17) Hughes JR, Goldstein MG, Hurt RD, et al:Recent advances in the pharmacotherapy of smoking. JAMA 281:72-76, 1999.
PubMed
P.64 掲載の参考文献
1) Durrant KL:Known and hidden sources of caffein in drug, food, and natural products. J Am Pharm Assoc 42:625-637, 2002.
 
2) Iversen SA, Murphy PG, Leakey TE, et al:Unsuspected caffeine toxicity complicating theophylline therapy. Hum Toxicol 3:509-512, 1984.
PubMed
3) Odom-White A, de Leon J:Clozapine levels and caffeine. J Clin Psychiatry 57:175-176, 1996.
PubMed
4) Jefferson JW:Lithium tremor and caffeine intake; two cases of drinking less and shaking more. J Clin Psychiatry 49:72-73, 1988.
 
5) Jonkman JH, Sollie FA, Sauter R, et al:The influence of caffeine on the steady-state pharmacokinetics of theophylline. Clin Pharmacol Ther 49:248-255, 1991.
PubMed
6) Carrillo JA, Benitez J:Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39:127-153, 2000.
PubMed
7) Perry PJ, Calloway RA, Cook BL, et al:Theophylline precipitated alterations of lithium clearance. Acta Psychiatr Scand 69:528-537, 1984.
PubMed
8) Sierles FS, Ossowski MG:Concurrent use of theophylline and lithium in a patient with chronic obstructive lung disease and bipolar disorder. Am J Psychiatry 139:117-118, 1982.
 
P.69 掲載の参考文献
1) Fraser AG:Pharmacokinetic interactions between alcohol and other drugs. Clin Pharmacokinet 33:79-90, 1997.
PubMed
2) Seixas FA:Alcohol and its drug interaction. Ann Intern Med 83:86-92, 1975.
PubMed
3) Weathermon R, Crabb DW:Alcohol and medication interactions. Alcohol Res Health 23:40-54, 1999.
PubMed
4) 森川恵一, 松原六郎, 村田哲人, ほか:Brotizolam投与後出現した健忘を主症状とする異常行動の2症例. 精神医学34:265-268, 1992.
 
5) Kannangara DW, Gallagher K, Lefrock JL:Disulfiram-like reactions with newer cephalosporins; cefmenoxime. Am J Med Sci 287:45-47, 1984.
PubMed
6) Fett DL, Vukov LF:An unusual case of severe griseofulvin-alcohol interaction. Ann Emerg Med 24:95-97, 1994.
PubMed
7) Green RM, Kelly KM, Gabrielsen T, et al:Multiple intracerebral hemorrhages after smoking "crack" cocaine. Stroke 21:957-962, 1990.
PubMed
8) 伊佐山浩道, 庵 政志:エタノールとベンゾジアゼピン類の相互作用. 治療76:65-70, 1994.
 
9) Portier H, Chalopin JM, Freysz M, et al:Interaction between cephalosporins and alcohol. Lancet 2:263, 1980.
PubMed
10) Neu HC, Prince AS:Interaction between moxalactam and alcohol. Lancet 1:1422, 1980.
PubMed
11) Wakabayashi I, Hatake K:Effects of ethanol on the nervous and vascular systems; the mechanisms of alcohol-induced hypertension. Jpn J Hyg 55:607-617, 2001.
 
12) Hoyumpa AM Jr:Alcohol interactions with benzodiazepines and cocaine. Adv Alcohol Subst Abuse 3:21-34, 1984.
PubMed
13) Wada K:Cocaine abuse in Japan. Jpn J Alcohol Drug Dependence 29:83-91, 1994.
 
14) Beach CA, Mays DC, Guiler RC, et al:Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics. Clin Pharmacol Ther 39:265-270, 1986.
PubMed
15) Mattila MJ:Alcohol and drug interactions. Ann Med 22:363-369, 1990.
PubMed
P.84 掲載の参考文献
1) 美濃 眞:ビタミン欠乏症と過剰症. 日本臨床57:2339-2344, 1999.
 
2) 大森正規, 荒川昌史, 新木信隆, ほか:一般内科外来における大衆薬および嗜好品の使用状況調査; preliminary report. 臨床薬理34:141-142, 2002.
 
3) Monterrey-Rodriguez J, Feliu JF, Rivera-Miranda GC:Interaction between warfarin and mango fruit. Ann Pharmacother 36:940-941, 2002.
 
4) Mousson Ch, Justrabo E, Rifle G, et al:Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure. Nephron 63:104-106, 1993.
PubMed
5) Flippo TS, Holder WD:Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B?? deficiency. Arch Surg 128:1391-1395, 1993.
PubMed
6) Morris JC, Beeley L, Ballantine N:Interaction of ethinyloestradiol with ascorbic acid in man. BMJ 283:503, 1981.
PubMed
7) Dysken MW, Cumming RJ, Channon RA, et al:Drug interaction between ascorbic acid and fluphenazine. JAMA 241:2008, 1979.
PubMed
8) Drinka PJ, Nolten WE:Hazards of treating osteoporosis and hypertension concurrently with calcium, vitamin D, and distal diuretics. J Am Geriatr Soc 32:405-407, 1984.
PubMed
9) Jacobus CH, Holick MF, Shao Q, et al:Hypervitaminosis D associated with drinking milk. N Engl J Med 326:1173-1177, 1992.
 
10) Yue Q-Y:Herbal drug curbicin and anticoagulant effect with and without warfarin ; possibly related to the vitamin E component. J Am Geriatr Soc 49:838, 2001.
 
11) Corrigan JJ, Marcus FI:Coagulopathy associated with vitamin E ingestion. JAMA 230:1300-1301, 1974.
PubMed
12) Berg MJ, Rivey MP, Vern BA, et al:Phenytoin and folic acid; Individualized drug-drug interaction. Ther Drug Monit 5:395-399, 1983.
PubMed
13) Morgan SL, Baggott JE, Vaughn WH, et al:The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9-18, 1990.
PubMed
14) Seligmann H, Potasman I, Wller B, et al:Phenytoin-folic acid interaction; a lesson to be learned. Clin Neuropharmacol 22:268-272, 1999.
 
15) Kempin SJ:Warfarin resistance caused by broccoli. N Engl J Med 308:1229-1230, 1983.
 
16) Lee M, Schwartz RN, Sharifi R:Warfarin resistance and vitamin K. Ann Intern Med 94:140-141, 1981.
PubMed
17) Pedersen FM, Hamberg O, Hess K, et al:The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 229:517-520, 1991.
PubMed
P.91 掲載の参考文献
1) Butner LE, Fulco PP, Feldman G:Calcium carbonate-induced hypothyroidism. Ann Intern Med 132:595, 2000.
PubMed
2) Grebe HB, Gregory PJ:Inhibition of warfarin anticoagulation associated with chelation therapy. Pharmacotherapy 22:1067-1069, 2002.
PubMed
3) Gora ML, Seth SK, Bay WH, et al:Milk-alkali syndrome associated with use of chlorthiazide and calcium carbonate. Clin Pharm 8:227-229, 1989.
PubMed
4) Spivey JM, Cummings DM, Pierson NR:Failure of prostatitis treatment secondary to probable ciprogloxacin-sucralfate drug interaction. Pharmacotherapy 16:314-316, 1996.
PubMed
5) Gaiser RR, Seem EH:Use of rocuronium in a patient with an open eye injury, receiveing magnesium medication, for preterm labour. Brit J Anaesth 77:669-671, 1996.
 
6) Snyder SW, Cardwell MS:Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 161:35-36, 1989.
PubMed
7) Mersebach H, Rasmussen AK, Kirkegaard L, et al:Intestinal absorption of levothyroxine by antacid and laxatives ; case stories and in vitro experiments. Pharmacol Toxicol 84:107-109, 1999.
 
8) Valli C, Schlthess H-K, Aspar R, et al:Interaction of nutrients with antacids; a complication during enteral tube feeding. Lancet 29:747-748, 1986.
 
9) Noyes M, Polk RE:Norfloxacin and absorption of magnesium-albumin. Ann Intern Med 109:168-169, 1988.
 
10) Nix DE, Watson WA, Lener ME, et al:Effects of aluminium and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin Pharmacol Ther 46:700-705, 1989.
PubMed
P.95 掲載の参考文献
1) Hay E, Derazon H, Bukish N, et al:Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet. J Emerg Med 22:349-352, 2002.
 
2) McCaughan D:Hazards of non-prescription supplements. Lancet 3:513-514, 1984.
 
3) Chiu TF, Bullard MJ, Chen JC, et al:Rapid life threatening hyperkalemia after addition of amiloride HCI/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy. Ann Emerg Med 30:612-615, 1997.
 
P.97 掲載の参考文献
1) 「飲食物・嗜好品と医薬品の相互作用」研究班 (編):飲食物・嗜好品と医薬品の相互作用. pp140-141, 薬業時報社, 東京, 1994.
 
2) Heller RF, Henry DA, Brent PJ:Enzyme induction by eating charcoal-grilled steak with no effect on blood lipids. Clin Exp Pharmacol Physiol 16:783-788, 1989.
PubMed
3) Kappas A, Alvares AP, Anderson KE, et al:Effect of charcoal-broiled beef on antipyline and theophylline metabolism. Clin Pharmacol Ther 23:445-450, 1978.
PubMed
4) 三上理一郎:薬物-食物相互作用による中毒. 日本医事新報3235:1986.
 
P.100 掲載の参考文献
1) Jejonc JL, Gusmini D, Brochard P:Isoniazid and reaction to cheese. Ann Intern Med 91:793, 1979.
 
2) Morinaga S, Kawasaki A, Hirata H, et al:Histamine poisoning after ingestion of spoiled raw tuna in a patient taking isoniazid. Intern Med 36:198-200, 1997.
 
3) Hauser MJ, Baier H:Interactions of isoniazid with food. Drug Intell Clin Pharm 16:617-618, 1982.
PubMed
4) Self TH, Chrisman CR, Baciewicz AM, et al:Isoniazid drug and food interactions. Am J Med Sci 317:304-311, 1999
PubMed
5) Taylor SL:Histamine food poisoning ; toxicology and clinical aspects. Crit Rev Toxicol 17:91-128, 1986.
PubMed
6) Senanayake N, Vyravanathan S, Kanagasuriyam S:Cerebrovascular accident after a "skipjack" reaction in a patient taking isoniazid. Br Med J 2:1127-1128, 1978.
 
P.103 掲載の参考文献
1) Vuori E, Henry JA, Ojanpera I, et al:Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 98:365-368, 2003.
PubMed
2) Dannawi M:Possible serotonin syndrome after combination of buspirone and St John's Wort. J Psychopharmacol 16:401, 2002.
PubMed
3) Chan BS, Graudins A, Whyte IM, et al:Serotonin syndrome resulting from drug interactions. Med J Aust 169:523-525, 1998.
PubMed
4) Mills KC:Serotonin syndrome. Am Fam Physician 52:1475-1482, 1995.
PubMed
5) Helander A, Some M:Dietary serotonin and alcohol combined may provoke adverse physiological symptoms due to 5-hydroxytryptophol Life Sci 67:799-806, 2000.
PubMed
6) Feldman JM, Lee EM:Serotonin content of foods; effect on urinary excretion of 5-hydroxyindoleacetic acid. Am J Clin Nutr 42:639-643, 1985.
PubMed
P.105 掲載の参考文献
1) Flannery EP, MacDonald BS, O'Leary DS, et al:Japanese-restaurant syndrome. N Engl J Med 285:414, 1971.
PubMed
P.107 掲載の参考文献
1) Mallhotra S, Dixit RK, Garg SK:Effect of an acid beverage (Coca-Cola) on the pharmacokinetics of carbamazepine in healthy volunteers. Methods Find Exp Clin Pharmacol 24:31-33, 2002.
 
2) Chin TW, Loeb M, Fong IW:Effect of an acid beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother 39:1671-1675, 1995.
PubMed
3) Jururatanasirikul S, Kleepkaew A:Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 52:235-237,1997.
 
4) Hurwitz A, Ruhl CE, Kimler BF, et al:Gastric function in the elderly; effects on absorption of ketoconazole. J Clin Pharmacol 43:996-1002, 2003.
PubMed
P.109 掲載の参考文献
1) Heck AM, Calis KA, McDuffie JR, et al:Additive gastrointestinal effects with concomitant use of olestra and orlistat. Ann Pharmacother 36:1003-1005, 2002.
PubMed
P.113 掲載の参考文献
1) 大森正規, 荒川昌史, 新木信隆, ほか:一般内科外来における大衆薬および嗜好品の使用状況調査:preliminary report. 臨床薬理34:141-142, 2002.
 
2) Honig PK, Gillespie BK:Drug interactions between prescribed and over-the-counter medication. Drug Safety 13:296-303, 1995.
PubMed
3) Smookler S, Bermudez AJ:Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Ann Emerg Med 11:482-484, 1982.
 
4) Pride M, Deamer RL:Over-the-counter cimetidine and theophylline interaction. Am Fam Physician 52:2180, 1995.
PubMed
5) Skop BP, Finkelstein JA, Mareth TR, et al:The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 12:642-644, 1994.
PubMed
6) http://wwwl.mhlw.go.jp/houdou/1211/h1120-1_15.html(ホームページ)
 
7) Somogyi A, Muirhead M:Pharmacokinetic interactions of cimetidine 1987. Clin Pharmacokinet 12:321-366, 1987.
PubMed
8) Fernandez E, Melewicz FM:Ranitidine and theophylline. Ann Int Med 100:459, 1984.
 

書評

最近チェックした商品履歴

Loading...